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ARTICLE
Giantin is required for intracellular N-terminal
processing of type I procollagen
Nicola L. Stevenson1, Dylan J.M. Bergen2,3,4, Yinhui Lu5,6, M. Esther Prada-Sanchez1,2, Karl E. Kadler5,6, Chrissy L. Hammond2, and
David J. Stephens1
Knockout of the golgin giantin leads to skeletal and craniofacial defects driven by poorly studied changes in glycosylation and
extracellular matrix deposition. Here, we sought to determine how giantin impacts the production of healthy bone tissue by
focusing on the main protein component of the osteoid, type I collagen. Giantin mutant zebrafish accumulate multiple
spontaneous fractures in their caudal fin, suggesting their bones may be more brittle. Inducing new experimental fractures
revealed defects in the mineralization of newly deposited collagen as well as diminished procollagen reporter expression in
mutant fish. Analysis of a human giantin knockout cell line expressing a GFP-tagged procollagen showed that procollagen
trafficking is independent of giantin. However, our data show that intracellular N-propeptide processing of pro-α1(I) is
defective in the absence of giantin. These data demonstrate a conserved role for giantin in collagen biosynthesis and
extracellular matrix assembly. Our work also provides evidence of a giantin-dependent pathway for intracellular procollagen
processing.
Introduction
The golgins are a family of coiled-coil domain proteins that ex-
tend out from the surface of the Golgi apparatus to tether
transport vesicles and other Golgi membranes (Munro, 2011).
The largest member of this family, giantin, is a tail-anchored
membrane protein with a predicted 37 cytosolic coiled-coil do-
mains (Linstedt and Hauri, 1993; Seelig et al., 1994). These
structural features are key attributes for a membrane tether;
however, to date, no tethering function for giantin has been
identified. Indeed, giantin loss does not block anterograde
transport (Lan et al., 2016; Stevenson et al., 2017) andmay in fact
accelerate it (Koreishi et al., 2013). Most studies also agree that
giantin is not essential to maintain Golgi morphology (Koreishi
et al., 2013; Lan et al., 2016; Puthenveedu and Linstedt, 2001;
Stevenson et al., 2017), although it may inhibit lateral tethering
between cisternae (Satoh et al., 2019; Stevenson et al., 2017).
Discrepancies between these studies are likely due to variation
in levels of depletion (Bergen et al., 2017), in genetic compen-
sation (Stevenson et al., 2017), and/or functional redundancy
with other golgins (Wong and Munro, 2014).
The most consistent observation from published work is that
giantin is required to regulate glycosylation (Kikukawa et al.,
1990; Koreishi et al., 2013; Lan et al., 2016; Petrosyan et al.,
2014; Stevenson et al., 2017) and ECM formation (Katayama
et al., 2018; Kikukawa and Suzuki, 1992; Lan et al., 2016).
Highly selective defects in O-glycosylation have been reported
following knockout (KO) of the GOLGB1 gene encoding giantin in
cells (Stevenson et al., 2017), zebrafish (Stevenson et al., 2017),
and mice (Lan et al., 2016). Enzyme distribution (Petrosyan
et al., 2014) and surface glycosylation patterns (Koreishi et al.,
2013) are more generally affected following siRNA depletion.
The secretion of ECM proteoglycans and collagen can also be
affected (Katayama et al., 2018; Kikukawa et al., 1990). The
primary phenotype shared by all GOLGB1 KO animal models is
the abnormal development of craniofacial structures, while
species-specific phenotypes include short limbs in rats
(Katayama et al., 2011) and ectopic mineralization of soft tissues
in zebrafish (Stevenson et al., 2017). Giantin is therefore im-
portant for skeletal development, and defects in ECM structure
likely underlie all these phenotypes.
In light of these observations, we hypothesized that giantin
may regulate secretion of the primary protein component of
skeletal ECM, fibrillar type I collagen. In mammals, this is pre-
dominantly built from heterotrimeric molecules composed of two
pro-α1(I) chains (encoded by the COL1A1 gene) and one pro-α2(I)
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chain (encoded by COL1A2). Structurally, each chain is made up of
a helical domain, composed of Gly–X-Y repeats, flanked by glob-
ular N- and C-propeptide domains (Canty and Kadler, 2005).
These chains are cotranslationally translocated into the ER lumen,
where they are post-translationally modified before folding into a
right-handed triple helical molecule. Trimeric procollagen is ex-
ported from the ER and transits the Golgi before being secreted
from the cell and assembled into fibrils in the ECM (Canty and
Kadler, 2005; Canty et al., 2004).
Prior to fibrillogenesis, the N- and C-propeptide domains of
procollagen are cleaved to promote correct alignment and po-
lymerization. Removal of the C-propeptide is particularly critical
as this induces self-assembly of collagen into fibrils (Hulmes
et al., 1989; Kadler et al., 1987; Kadler et al., 1990; Miyahara
et al., 1984; Miyahara et al., 1982). Retention of the
N-propeptide, on the other hand, does not preclude fibril as-
sembly but can affect fibril morphology (Bornstein et al., 2002;
Hulmes et al., 1989; Romanic et al., 1992). C-terminal processing
is performed by BMP-1/tolloid-like family metalloproteinases
(Kessler et al., 1996) while ADAMTS2, -3, and -14 cleave the
N-propeptide (Bekhouche and Colige, 2015; Colige et al., 1997;
Colige et al., 2002; Fernandes et al., 2001). Meprin α and meprin
β have also been implicated in procollagen processing (Broder
et al., 2013).
In this study, by using a combination of fin fracture assays in
golgb1 mutant zebrafish and biochemical assays in giantin KO
cells, we demonstrate that giantin function is required to facil-
itate normal fracture repair and for intracellular N-terminal
processing of type I procollagen.
Results
Homozygous (HOM) golgb1 mutant fish have a higher
incidence of fracture
To investigate the role of giantin in the deposition of skeletal
ECM, we examined our previously published HOM golgb1X3078/-
X3078 mutant zebrafish line for bone defects (Bergen et al., 2017).
Focusing on the caudal fin (Bergen et al., 2019), we observed an
unusually high number of naturally occurring fractures in the
hemirays of HOM individuals compared with WT and hetero-
zygote (HET) siblings. This was seen both in terms of the
number of injured fish and the number of fractures per indi-
vidual. Indeed, at 7 mo old, 76% of HOM fish had acquired at least
one fracture compared with just 33% of WT and 27% of HET fish
(Fig. 1 A). The mean number of fractures per individual was 0.4
for WT and HETs and 1.8 for mutants. Interestingly, 12% of
golgb1X3078/X3078mutants had ≥4 fractures. This was never seen in
WT or HET siblings. These were often in the proximal half of the
fin and occurred either consecutively along one ray or adjacent
to each other in parallel rays (Fig. 1 B). There was also one HOM
individual carrying fractures that had fused together, indicating
aberrant fracture repair with excessive calcification (Fig. 1 B).
golgb1 mutant fish show abnormal mineralization patterns
during fracture repair
To investigate this further, fractures were experimentally in-
duced in caudal fin hemirays of mutant andWT fish as described
previously (Geurtzen et al., 2014; Tomecka et al., 2019). Injured
fishwere stained with calcein at different time points tomonitor
calcification of newly formed bone matrix in the callus. Calcein
labeling was first visible in WT fish 4 d post injury (dpi),
whereas labeling was already apparent at the fracture site in
HOM fish at 2 dpi (Fig. 1, C and D). In both cases, labeling in-
tensity continued to increase over time, peaking at 10 dpi. Cal-
cein fluorescence was substantially greater in the fractures of
HOM fish throughout the assay. This is most evident at 10 dpi,
when it was ∼400% brighter in the mutants. Levels of calcein-
accessible calcium are therefore elevated in the fractures of
golgb1X3078/X3078 fish. This shows that premature and enhanced
calcification occurs in the mutant fish.
Expression of the col1a1 gene is reduced in golgb1
mutant fractures
Mineralization is dependent on the correct spatio-temporal de-
position of a collagen matrix to ensure the right amount of
calcification occurs at the right time (Michigami, 2019). We
therefore assessed type I collagen expression in the repairing
fractures. We crossed golgb1X3078/X3078 fish with a col1a1a:GFP
promoter reporter line and performed the same fracture ex-
periments as above but without the calcein stain. Expression of
col1a1a:GFP at the fracture site relative to healthy bone was
highest at 4 dpi in both HET and HOM fractures (Fig. 1, E and F).
Expression returned to normal levels by 14 dpi. Interestingly,
col1a1a:GFP expression was lower in the fractures of HOM mu-
tant fish compared with HETs at both 4 and 7 dpi, when pro-
moter activity was at its peak. This agrees with our previously
published RNA sequencing (RNA-seq) data, which show a re-
duction in COL1A1 mRNA in GOLGB1 KO human telomerase-
immortalized retinal pigment epithelial (hTERT-RPE1) cells
relative to WT (Stevenson et al., 2017). No obvious difference in
callous width or Alizarin Red staining (ARS) was observed (Fig.
S1, A and B).
There are no gross changes in collagen structure in the
mutant fins
We next looked to see if we could identify a change in collagen
synthesis and deposition that would account for the lower ex-
pression of COL1A1 mRNA and decreased GFP signal. The distal
third of the caudal fin was amputated and lysed to produce a
sample rich in bone collagen to analyze by immunoblotting.
Collagen blots were similar between the WT and mutant fins,
suggesting collagen is predominantly synthesized and processed
normally in the mutants (Fig. S1 C).
We considered the possibility that collagen secretion or
structural defects occurring early during synthesis could later be
resolved in the tissues as they mature. We therefore decided to
test younger, nascent tissue to look for phenotypes. First, we
amputated the distal third of the caudal fin and then let it re-
generate for 5 d before amputating and lysing the new regen-
erated tissue (Fig. S1, D and E). Second, we lysed young larvae at
5 days post-fertilization (dpf) to probe collagen early in devel-
opment (Fig. S1, F and G). In both cases, we failed to see any
difference in collagen migration through the gel by immunoblot
or by Coomassie stain. The lysates were not decalcified, which
Stevenson et al. Journal of Cell Biology 2 of 18
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Figure 1. Fracture defects in golgb1 mutant zebrafish. (A) Quantification of the number of fractures naturally found in the caudal fin of WT and
golgb1X3078/X3078 heterozygous and HOMmutant fish at 7 mo old. Data show percentage of fish with × number of fractures (WT = 12 fish, HET = 11 fish, HOM =
25 fish from two independent crosses). Statistics performed with a Mann-Whitney U test. (B) Fluorescence images of naturally occurring caudal fin defects in
golgb1X3078/X3078 fish stained with ARS. White arrows indicate fractures. Scale bar = 200 µm. (C and D) Quantification (C) and representative brightfield and
fluorescent images (D) of experimentally induced fractures in golgb1wt/wt and golgb1X3078/X3078 caudal fins on different dpi. Bone was stained with calcein at each
time point before imaging. (C) Calcein intensity in fractures was measured relative to that of healthy adjacent bones. Lower exposure images than those in D
were used for quantification to avoid saturation. Each dot represents one fracture. Bars showmedian and interquartile range (two fish per line quantified, each
with three fractures). (D) Proximal end of bone is at the top of image. Scale bar = 200 µm. (E) Representative brightfield and fluorescent images of ex-
perimentally induced fractures in the caudal fin of golgb1wt/X3078 and golgb1X3078/X3078 fish expressing a col1a1a:GFP promoter reporter at different time points.
Proximal end of bone is at the top of image. Scale bar = 200 µm. (F)Quantification of col1a1a:GFP signal at the fracture site relative to an adjacent healthy bone.
Each dot represents one fracture. Orange bars indicate median and interquartile range. At time points 4 and 7 dpf, 11 fish per line were quantified. At time
points 14 and 21 dpf, n = 6 HETs and n = 4 HOM fish quantified. All data were collected in a single experiment. All P values were calculated with the Mann-
Whitney U test comparing the means for each fish, three fractures per fish. A.U, arbitrary units.
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may explain the absence of an obvious collagen abundance by
Coomassie stain.
We next investigated collagen fibril structure in the ECM of
mutant bones. Again, on the assumption that we were most
likely to see a phenotype in younger tissue, we processed re-
generated caudal fins for analysis by transmission EM (TEM).
Imaging of tissue from four individuals of each genotype failed
to show any consistent differences in fibril structure or abun-
dance (Fig. S1 H); however, there was considerable variation
between individuals. Collagen fibrils in the bone had regular
contours in cross section, and collagen fibril D-periodicity was
normal. The mutants also produced a structurally normal
basement membrane in the skin (Fig. S1 I)
Expression and secretion of type I collagen is elevated in
giantin KO cells
Given the absence of gross morphological changes in the ma-
turing collagen matrix of mutant fish, we next focused on the
early steps of secretion. For this, we turned to our previously
published GOLGB1 KO hTERT-RPE1 cell line as a more tractable
system for studying intracellular events (Stevenson et al., 2017).
Our previously published RNA-seq data show that gene ex-
pression of COL1A1 is reduced in giantin KO cells (Stevenson
et al., 2017). In contrast, immunoblot analysis shows that KO
cells contain higher levels of type I collagen protein relative to
WT cells (Fig. 2, A and B). While statistical testing of pooled data
does not reveal a detectable difference here, comparison of in-
dividual experiments (color coded in Fig. 2 B) shows a consistent
increase of pro-α1(I). Interestingly, higher procollagen levels are
not due to protein retention since KO cells also secrete similar or
higher amounts of type I collagen compared with WT cells, both
in absolute terms and relative to the intracellular pool (Fig. 2, C
and D). There is also no evidence of collagen overmodification or
ER dilation (Stevenson et al., 2017), as would be expected if the
collagen had been retained (Ishida et al., 2006). Immunofluo-
rescence labeling of type I collagen in non-permeabilized WT
and KO cells verified that this excess of secreted collagen is in-
corporated into the ECM (Fig. 2, E and F). In fact, the cell-derived
matrix from giantin KO cells often contained thicker fibers that
were more intensely labeled for type I collagen, but these were
difficult to quantify.
Procollagen trafficking through the early secretory pathway is
unaffected by loss of giantin
We next tested whether altered procollagen synthesis and de-
position is the result of changes to procollagen trafficking
through the secretory pathway. To this end, we generated WT
and giantin KO cell lines stably expressing low levels of pro–
streptavidin binding protein (SBP)–GFP-COL1A1 (GFP-COL1A1;
McCaughey et al., 2019). This construct encodes pro-α1(I) with a
GFP and SBP tag inserted upstream of the N-propeptide cleavage
site (Fig. 3 A). The SBP tag allows controllable bulk release of the
procollagen from the ER using the Retention Using Selective
Hooks (RUSH) assay (Boncompain et al., 2012). This assay relies
on coexpression of a KDEL-streptavidin hook to bind the SBP
and anchor the GFP-COL1A1 in the ER. The addition of biotin
releases GFP-COL1A1. The hook is co-expressed from a
bicistronic vector with mCherry-sialyltransferase (mCh-ST),
which labels the Golgi.
In WT cells, GFP-COL1A1 first accumulates around the
mCh-ST–positive Golgi compartment upon release (Fig. 3 B and
Video 1). Fixation at this time point followed by immunolabeling
of Golgi markers confirmed that this predominantly represents
the GFP-COL1A1 entering the cis-Golgi (Fig. 3 E). Shortly after
cis-Golgi filling, the GFP-COL1A1 progresses through the Golgi
into the mCh-ST–positive cisternae before leaving the Golgi in
tubular vesicular carriers (Fig. 3, B and C, arrows). This “short
loop” pathway from the ER to cis-Golgi in the absence of dis-
cernible carriers has been described previously (McCaughey
et al., 2019). Here, we found that GFP-collagen also traverses
this pathway in the giantin KO cells (Fig. 3 C and Video 2).
To measure the kinetics of ER-to–cis-Golgi transport, we
quantified the time between biotin addition and the appearance
of GFP-COL1A1 in the cis-Golgi. Trafficking rates were equiva-
lent in both cell lines (Fig. 3 D), indicating the giantin KO phe-
notypes are not due to the use of an alternative procollagen
trafficking route or faster kinetics.
Giantin KO cells exhibit defects in processing of type
I procollagen
During these experiments, we observed that giantin KO cells
stably expressing GFP-COL1A1 were often surrounded by ex-
tracellular GFP-positive fibers. Immunofluorescence with a pro-
α1(I) antibody identified these as collagen fibrils, indicating that
the GFP-tag is incorporated into the ECM (Fig. 4 A). No GFP-
COL1A1–positive fibrils could be detected in the matrix of
WT cells despite an abundance of collagen, and the expression of
GFP alone did not label the ECM.
In our reporter construct, GFP is inserted upstream of the
N-propeptide cleavage site and is expected to be removed during
procollagen processing (Fig. 3 A). The presence of GFP in the
ECM therefore implies that either N-propeptide processing is
defective or that free N-propeptides are abnormally interacting
with collagen fibrils. To investigate this, we assayed secretion by
immunoblotting. In both the media and lysate fractions of WT
cultures, a dominant GFP-positive band was discernible at ∼60
kD, which corresponds to the size of the tagged N-propeptide
(Fig. 4 B). In KO cells, however, the dominant GFP-positive band
was detected at ∼200 kD. This is consistent with the size of
unprocessed, tagged procollagen. No band was discernible at
∼60 kD in the KO cells, even after enrichment by immunopre-
cipitation (Fig. S2 A), suggesting that N-propeptide cleavage
does not take place. These results were supported by additional
immunoblots detecting the SBP tag (Fig. 4 C). In this instance,
full-length procollagen is also evident in WT cells, likely due to
the higher affinity of the SBP antibody, but the N-propeptide
remains undetectable in the KO cells.
To verify our interpretation of these observations with re-
spect to the N-propeptide, we performed immunoblots using
antibodies specifically targeting the N- and C-propeptide do-
mains of pro-α1(I). C-propeptide cleavage was comparable in
WT and KO cells (Fig. 4 D), with a band of ∼30 kD detected as
expected. However, an antibody against the N-propeptide de-
tected a band of ∼60 kD in WT cell lysates that was again
Stevenson et al. Journal of Cell Biology 4 of 18
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completely absent in the KO cultures (Fig. 4 E). This
N-propeptide band was also detected in the media of WT cells
but only following enrichment by immunoprecipitation (Fig. S2
A). It is therefore present but in low quantities. Full-length col-
lagen protein levels were again higher in the KO cells (Fig. 4 F).
We also used the N-propeptide–specific antibody to im-
munolabel the ECM of WT and KO cells. While this antibody did
not label the cell-derived matrix ofWT cells, it did label fibrils in
the KO cell matrix where it colocalized with the extracellular
GFP signal (Fig. 4 G). Together, these data indicate that the
presence of GFP in the collagen matrix of KO cells is due to a
failure in N-propeptide cleavage.
Secretion of unprocessed procollagen has been reported in the
absence of Hsp47 (Ishida et al., 2006); however, Hsp47 levels in
the KO cells were normal (Fig. S2, B and C). We also hypothesized
that the absence of N-propeptide in the KO cells could be due to its
increased degradation, but treatment of KO cells with proteasomal
and lysosomal inhibitors did not render it detectable (Fig. S2 D).
N-propeptide cleavage occurs inside the cell in RPE1 cells
The detection of free N-propeptide in WT cell lysates is consis-
tent with intracellular cleavage. N-propeptide abundance was
also sensitive to proteasomal and lysosomal inhibitors in these
assays, consistent with an intracellular pool (Fig. S2 D). It is,
however, also possible that the observed N-propeptide is asso-
ciated with the cell surface and internalized for degradation. To
confirm that processing is indeed an intracellular event, we
performed two further biochemical assays on theWT cells stably
expressing the GFP-COL1A1.
First, a cell surface trypsin digest was performed to see
whether the N-propeptide is in fact at the plasmamembrane. As
expected, treatment of cell cultures with trypsin for increasing
amounts of time resulted in the gradual degradation of EGFR, a
known resident of the plasma membrane (Fig. 5 A). Both HSP47,
a known resident of the secretory pathway, and free
N-propeptide were unaffected. As a control, cells were also
briefly permeabilized with digitonin before assay to grant the
trypsin access to intracellular proteins. This resulted in the
complete degradation of EGFR, including EGFR previously
protected in recycling endosomes, whereas soluble cytosolic
proteins such as GAPDH and DIC74 were lost during per-
meabilization. HSP47 and the N-propeptide were again unaf-
fected, suggesting that they remained protected within
digitonin-resistant membranes, such as those of the secretory
pathway. The N-propeptide is therefore not present on the cell
surface or in endosomes.
Figure 2. pro-α1(I) is more abundant in giantin KO RPE1 cells. (A) Immunoblot of pro-α1(I) and dynein intermediate chain (DIC74, housekeeping) in cell
lysates taken fromWT and giantin KO cells. (B) Densitometry of the semiquantitative ECL immunoblots represented in A. Dots show individual replicates, and
each independent experiment is color coded between cell lines. Bars depict median intensity of pro-α1(I) (COL1A1) normalized against DIC74 (n = 4 biological
replicates). Error bars = interquartile range. Statistical test: Mann-Whitney U test. (C) Immunoblot of media (M) and cell lysate (L) fractions taken fromWT and
giantin KO cell cultures after 16-h incubation with serum-free medium plus 50 µg/µl ascorbate. (D) Ratio of extracellular versus intracellular levels of collagen
as measured from secretion assays represented in C. pro-α1(I) (COL1A1) levels measured by densitometry from semiquantitative enhanced chemiluminescent
blots and normalized against DIC74 before calculating ratios. Dots show individual replicates, and each independent experiment is color coded between cell
lines. Bars depict median and interquartile range (n = 7 biological replicates). Statistical test: Mann-Whitney U test. (E)Maximum projections of widefield image
stacks showing PFA fixed, unpermeabilized cells immunolabeled for endogenous pro-α1(I) (COL1A1, green). Nuclei are stained with DAPI (blue). Scale bars = 10
µm. (F) The cell-derived matrix produced by WT and giantin KO cells imaged as tilescans of confocal z-stacks of antibody-labeled pro-α1(I) presented as
maximum projections. Scale bars = 2 µm (E) and 100 µm (F). A.U., arbitrary units.
Stevenson et al. Journal of Cell Biology 5 of 18
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Figure 3. ER-Golgi trafficking of pro-α1(I) is unperturbed in giantin KO RPE1 cells. (A) Schematic of the pro-SBP-GFP-COL1A1 construct used in this
study. SS, signal peptide. (B and C) Single-plane confocal stills taken from live imaging movies of aWT (B) and giantin KO (C) cell stably expressing GFP-COL1A1
Stevenson et al. Journal of Cell Biology 6 of 18
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Secreted proteins can be prevented from leaving the Golgi
using a temperature block at 20°C. In our second assay, we
therefore performed secretion assays at 20°C to see whether
procollagen can still be processed if trapped in the ER and Golgi.
This would localize cleavage activity to one of these compart-
ments. To ensure we only assayed procollagen affected by the
temperature block, we first flushed out all the preexisting pro-
collagen by treating cells with ascorbate to encourage secretion
and cycloheximide to prevent synthesis of new procollagen. This
removed most of the N-propeptide from the cell layer (Fig. 5 B).
The cycloheximide was then washed out to permit expression of
new protein, and cells were incubated at 37°C or 20°C overnight
in the presence of ascorbate before performing a secretion assay.
The accumulation of procollagen in the Golgi at 20°C was con-
firmed by immunofluorescence (Fig. 5 C). Consistent with in-
tracellular processing, immunoblotting of the assay samples
detected free N-propeptide at both temperatures (Fig. 5 B);
however, as expected, the N-propeptide was only secreted at
37°C. Altogether, these results are consistent with N-terminal
procollagen processing taking place in the early-mid secretory
pathway.
N-terminal processing of type I procollagen is defective in
other giantin KO lines
Since the above data were derived from a single clone of GOLGB1
KO cells, we generated new KO cell lines in which to validate our
findings. This time we targeted exon 13 of the GOLGB1 gene
(instead of exon 7) and used the lentiCRISPRv2 system (Sanjana
et al., 2014; Shalem et al., 2014) for transfection to vary our
approach. We obtained three clones with different indel muta-
tions (Fig. S3 A). Immunoblots with a giantin polyclonal anti-
body confirmed the loss of full-length protein, although hints of
a potential truncated form could be seen in low abundance
(Fig. 6 A). Immunofluorescence staining with two different
polyclonal antibodies directed against giantin did not detect any
protein (Fig. 6 B). As previously described for the original KO
line (Stevenson et al., 2017), no gross changes in Golgi mor-
phology or ER exit site abundance were apparent following loss
of giantin (Fig. 6 B).
Using the exon 13 mutant clones, we derived new stable cell
lines expressing GFP-COL1A1. We also made a new WT GFP-
COL1A1 stable line to be sure of the WT phenotype. As with our
original clone, we were not able to detect cleaved N-propeptide
in either the media or lysate fractions from these new KO cell
cultures (Fig. 6 C). We did, however, note some variability in the
molecular weight of the procollagen bands detected between
clones, perhaps suggesting additional processing defects or de-
ficiencies in post-translational modifications. Imaging of the
new KO clones again also confirmed incorporation of the GFP-
tag and the N-propeptide into the extracellular collagen matrix
in two of these lines (Fig. 6 D). The phenotypes of the new WT
stable cell lines also validated those of the original (Fig. 6, C and
D). Overall, these results confirm that N-propeptide processing
is defective in the absence of giantin.
Although we found that RPE1 cells do secrete and assemble
type I collagen in their matrix, their primary function is to
produce nonfibrillar basement membrane. Due to the skeletal
phenotypes observed in the animal models, we therefore de-
cided to further test our observations in the more relevant
MC3T3 mouse osteoblast precursor cell line. Using CRISPR-Cas9
genome engineering, we generated two mutant lines with
gRNAs targeting either exon 2 or exon 8. The latter was geno-
typed to confirm mutation (Fig. S3 B). Almost a complete loss of
giantin was apparent in these clones both by immunoblot and
immunofluorescence (Fig. S4, A and B); however, some protein
did persist. Again, Golgi morphology was unaffected by the loss
of giantin (Fig. S4 B).
Unlike the RPE1 cells, overall levels of expression of full-
length procollagen were comparable between the mutants and
WT cells in this line (Fig. S4 A). To study procollagen processing,
we transiently transfected cells with GFP-COL1A1 and per-
formed a GFP-trap on the media and lysate fractions of WT and
mutant cultures (Fig. S4 C). Note, transfection efficiencies were
variable between lines but were always low, making analysis
difficult. In agreement with the RPE1 cells, immunoblots of the
cell culture media showed that the N-propeptide is secreted by
WT cells but not by the mutant lines (Fig. S4 C). Small amounts
of the N-propeptide were, however, detectable in the KO cell
lysates, suggesting some cleavage is taking place. Unfortunately,
as in the RPE1 cells, we were unable to detect endogenous free
N-propeptide in the MC3T3 cell lysates (Fig. S4 A). Whether this
is because it is not present or is in too low abundance is not clear.
Overall, the difference in N-propeptide abundance and locali-
zation between the WT and giantin mutant MC3T3 is consistent
with procollagen N-terminal processing being sensitive to
giantin function, even though the outcome manifests slightly
differently between systems.
Discussion
In this study, we demonstrate for the first time that giantin is
required for N-terminal, but not C-terminal, processing of type I
procollagen. In its absence, procollagen intermediates still
bearing the N-propeptide are secreted and incorporated into the
ECM. Unlike the C-propeptide, retention of the N-propeptide
does not preclude fibril formation (Hulmes et al., 1989;
Miyahara et al., 1984; Miyahara et al., 1982; Romanic et al., 1992);
thus, it is not surprising that collagen fibrils are formed. We also
(green) and transiently transfected with mCh-ST (magenta) and an ER RUSH hook. Frame times in the top left corner indicate the time (minutes) after biotin
addition, which releases GFP-COL1A1 from the ER hook. Scale bars = 10 µm on overview and 1 µm on zoom. White arrows indicate the appearance of pe-
ripheral GFP-COL1A1 punctate. Orange arrows indicate emerging post-Golgi carriers. See also videos. (D) Quantification of the time taken for GFP-COL1A1 to
first appear at the Golgi in videos represented in B and C. Each dot represents one cell (16 WT cells and 13 giantin KO cells), and videos were collected over
seven independent experiments. Bars represent median and interquartile range. Results are not significant using a Mann-Whitney U test. (E) Maximum
projections of confocal z-stacks of WT and giantin KO cells imaged live as in B and C and then fixed with PFA as soon as the GFP-COL1A1 appeared around the
Golgi. Cells were then immunolabeled for the Golgi marker GM130 (blue). Scale bars = 10 µm.
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Figure 4. Procollagen processing is defective in giantin KO RPE1 cells. (A) Representative images of WT and giantin KO cells expressing GFP-COL1A1 or
GFP alone as indicated and immunolabeled for pro-α1(I) (COL1A1, magenta). Cells are not expressing a RUSH hook. Nuclei are stained with DAPI (blue). Images
are maximum-intensity projections of widefield z-stacks. Scale bars = 10 µm. (B–F) Immunoblots of secretion assays showing the medium (M) and lysate (L)
fractions ofWT and giantin KO cell cultures immunoblotted for GFP and tubulin (B), SBP and tubulin (C), pro-α1(I) C-propeptide (LF41 antibody) and tubulin (D),
pro-α1(I) N-propeptide (LF39 antibody; E), and pro-α1(I) and GAPDH (F). Black arrows indicate full-length procollagen, and red arrows highlight N-propeptide
bands. (G) Maximum-intensity projection widefield z-stacks of WT and giantin KO cells stably expressing GFP-COL1A1 immunolabeled for the pro-α1(I)
N-propeptide (LF39 antibody). Scale bars = 10 µm. Ab, antibody.
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found that the N-propeptide is cleaved inside the cell. Alto-
gether, these data indicate the presence of a giantin-dependent
intracellular pathway for procollagen processing.
The most likely cause of the observed processing deficiency
in KO cells is a defect in the expression, trafficking, or pro-
cessing of an N-proteinase. Although we have not yet identified
any trafficking defects in our giantin KO cells either generally
(Stevenson et al., 2017) or specifically for procollagen, it is
possible that other cargoes such as processing enzymes will be
affected. To date, five enzymes have been implicated in the
N-terminal processing of type I procollagen: ADAMTS2,
ADAMTS3, ADAMTS14 (Bekhouche and Colige, 2015; Colige et al.,
1997; Colige et al., 2002; Fernandes et al., 2001), meprin-α, and
meprin-β (Broder et al., 2013). Our previous RNA-seq analysis of
RPE1 cells (ArrayExpress accession no. E-MTAB-5618) did not
detect any ADAMTS2 transcript, even in WT cells; however,
ADAMTS3 and ADAMTS14 mRNA was present, and interestingly,
their expression was down-regulated following giantin KO
(Stevenson et al., 2017). Alternatively, giantin could affect the
trafficking of an inhibitor of N-proteinase activity, such as TIMP3.
Unfortunately, our attempts to further these lines of inquiry have
been unfruitful due to a lack of suitable reagents.
A second possible cause of defective processing is glycosyla-
tion deficiency. Indeed, it has been shown that C-proteinase
Figure 5. Intracellular procollagen processing in RPE1 cells. (A) Immunoblots of WT RPE1 cells stably expressing GFP-COL1A1 that were exposed to trypsin
for the indicated amount of time before lysis. Lanes 2 and 8 contain lysates from cells that were treated with trypsin + an equal volume of soybean trypsin
inhibitor as a negative control. Samples in lanes 1–6 were treated with digitonin for 2 min before trypsin treatment to permeabilize the cells. The DIC74, HSP47,
and EGFR blots shown are all from a single membrane, but the scan images were digitally cut in half and the halves swapped to align the correct lanes with the
±digitonin labels in the figure. (B) Immunoblots of secretion assays performed on WT RPE1 cells incubated at 20°C or 37°C overnight in the presence of
ascorbate. Prior to overnight incubation, cells were treated with cycloheximide (CHX) and ascorbate to flush through pre-existing procollagen. Lane 7 contains
a lysate sample taken at the end of this cycloheximide treatment to show the extent to which this removed the procollagen. Lane 1 and 2 samples showmedia
(M) and lysate (L) fractions of a cell culture treated with ascorbate only without the cycloheximide. (C) Single-plane widefield images of cells subjected to the
experimental conditions of B but fixed after overnight incubation at 20°C or 37°C in the presence of ascorbate. Cells were stained by immunofluoresence for
GM130 (magenta) to label the Golgi and DAPI stained (blue) to show the nuclei. Scale bars = 10 µm.
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Figure 6. Validation of processing defects in other giantin mutant RPE1 lines. (A) Immunoblot of lystates from WT and giantin exon 13 KO RPE1 clones
probed for giantin (polyclonal against full-length protein) and tubulin (housekeeping). (B) Widefield maximum-projection images of WT and giantin KO RPE1
cell clones immunolabeled for the N-terminus (N-term) of, and full-length (FL) giantin; ER exit sites (Sec31); and the Golgi (GRASP65) as indicated. Scale bar =
10 µm. (C) Immunoblots of secretion assays performed on WT and giantin KO clones stably expressing GFP-COL1A1 and untransfected giantin KO cells (unTF).
Blots show the medium (M) and lysate (L) fractions of each cell population immunoblotted for GFP, SBP, and pro-α1(I) N-propeptide as indicated. (D)
Maximum-projection widefield images of GFP signal in giantin KO clones stably expressing GFP-COL1A1 and immunolabeled for pro-α1(I) N-propeptide
(magenta). Scale bar = 10 µm.
Stevenson et al. Journal of Cell Biology 10 of 18
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activity is sensitive to inhibitors of N-glycosylation (Duksin
et al., 1978). Loss of giantin function affects the enzyme com-
position of the Golgi and the O-glycosylation of specific sub-
strates (Lan et al., 2016; Stevenson et al., 2017). It is thus feasible
that at least one of the N-proteinases is incorrectly glycosylated
in giantin KO cells in such a way as to impede activity. Alter-
natively, procollagen itself may be incorrectly glycosylated,
preventing its identification as a substrate. We did perform a
global analysis of glycoproteins by mass spectrometry, but as
predicted from previous results (Stevenson et al., 2017), there
were no differences in the major glycosyl chains produced by
WT or KO cell lines. This approach did not permit us to deter-
mine the glycosylation of specific substrates.
A crucial observation made in this study is that N-propeptide
processing occurs, at least in part, inside the cell. More specifi-
cally, our data suggest it takes place in the early-mid secretory
pathway since Golgi exit is not required for cleavage. There is
precedent for the detection of intracellular procollagen pro-
cessing in both chick and mouse tendons (Canty-Laird et al.,
2012; Canty et al., 2004; Humphries et al., 2008). In these
studies, processed forms of type I procollagen were detected in a
detergent-soluble fraction from tendon explants, consistent
with an intracellular pool. Furthermore, inhibition of procolla-
gen secretion by Brefeldin A treatment, which causes the cis-
and medial-Golgi machinery to accumulate in the ER, does not
prevent N-terminal processing, indicating procollagen can be
processed in the early secretory pathway where giantin is lo-
cated (Canty-Laird et al., 2012). Considering this, together with
the data presented here, we conclude that giantin is a crucial
component of an intracellular pathway of procollagen
processing.
Comparison of our giantin mutant cell lines suggests that
processing defects can manifest in different ways. We previ-
ously showed that cells alter gene expression to compensate for a
lack of giantin, and perhaps the way different systems com-
pensate can affect outcome. This would certainly appear to be
the case when comparing phenotypes in animal models. Unlike
RPE1 cells, small amounts of N-propeptide were detected in the
KO MC3T3 cells. Whether this N-propeptide pool is in the se-
cretory pathway and is a bona fide product of a processing event,
or whether it is present in the degradative pathway as a by-
product of procollagen turnover after overexpression was not
ascertained. The fact that it is not secreted perhaps suggests the
latter is more likely. These cell populations also retain some
giantin, and so the phenotype may not be as complete as in the
RPE1 cells. Similarly, in these experiments, a human recombi-
nant procollagen was expressed in a mouse cell line, which may
affect how the procollagen is recognized and processed.
We found that COL1A1 promoter activity and mRNA levels are
reduced in both golgb1X3078/X3078 mutant zebrafish and KO cells,
respectively (Stevenson et al., 2017). This contrasts with protein
levels, which are more abundant in vitro, at least in the RPE1
cells, which have a more complete processing defect than the
MC3T3 cells. Previous studies have suggested that the pro-α1(I)
N-propeptide is capable of acting as a negative regulator of pro-
α1(I) synthesis (Hörlein et al., 1981; Oganesian et al., 2006; Paglia
et al., 1979; Wiestner et al., 1979). Importantly, the point of
inhibition occurs during translational chain elongation or ter-
mination (Hörlein et al., 1981; Oganesian et al., 2006; Paglia
et al., 1979). Thus, we speculate that despite the reduced abun-
dance of mRNA transcript, translation of pro-α1(I) is more ef-
ficient in giantin KO RPE1 cells in the absence of inhibitory
N-propeptide. Consistent with reports that only endogenously
expressed N-propeptide can inhibit translation, we were unable
to rescue our phenotypes by supplementing media with re-
combinant type I procollagen N-propeptide.
Human patients with mutations affecting N-terminal pro-
cessing of type I procollagen suffer from Ehlers-Danlos syn-
drome (EDS) type VII, a disease characterized by joint
hypermobility, skin hyperextensibility, and dislocations (ar-
throchalasia type, formally type VIIA and VIIB) or skin fragility
(type VIIC/dermatosparatic type; Byers et al., 1997; Colige et al.,
1999; Giunta et al., 1999; Smith et al., 1992). Collagen fibers in
dermatosparatic-type patients appear hieroglyphic in cross
section and have irregular contours in type VIIB patients
(Malfait et al., 2013; Van Damme et al., 2016). ADAMTS2-
deficient mice also have thinner collagen fibrils in the skin (Li
et al., 2001). We primarily examined collagen fibril structure in
the bones of the golgb1X3078/X3078 fish; however, skin collagen was
also present in these samples, and we did not see any structural
changes. The fact that the fish do not recapitulate an EDS phe-
notype could suggest that the pathways affected by giantin loss
may be ADAMTS2 independent, especially given the sensitivity
of the RPE1 cells, which do not express ADAMTS2.
As previously described, golgb1X3078/X3078 mutant zebrafish
show developmental growth delay, elongated craniofacial
structures, and ectopic mineralization of soft tissue (Bergen
et al., 2017; Stevenson et al., 2017). Here, we additionally re-
port that mutant adult caudal fins accumulate significant num-
bers of fractures and show defects in the maturation of newly
deposited matrix during fracture repair. Our observations of
increased calcein labeling in mutant fish fractures is consistent
with either increased osteoid formation or hypermineralization.
We previously reported that expression of the glycosyltrans-
ferase GALNT3 is reduced in both GOLGB1 KO cells and zebrafish
(Stevenson et al., 2017). GALNT3 is required to glycosylate and
activate FGF23, which is an inhibitor of bone mineralization
(Wang et al., 2008). The observed defects in fracture repair
could therefore be the result of FGF23 deficiency. Alternatively,
or perhaps additionally, collagen N-propeptides have been
linked to the differentiation and apoptosis of osteoblasts
(Oganesian et al., 2006) and osteoclasts (Hayashi et al., 2011),
respectively. We have not been able to directly demonstrate that
the procollagen processing defects observed in cells translate to
fish; however, it is interesting to speculate that processing de-
fects may affect the balance of bone synthesis and resorption in
the mutant fractures. The significant impact of the loss of
giantin on mineralization likely explains why mutant animals
primarily present with skeletal defects and why other type I
collagen-rich tissues, such as skin, are less affected.
The observed increased incidence of fractures in mutants
could result from an increased frequency of fractures in brittle
bones or an accumulation of fractures due to slow healing. Al-
though fracture repair is delayed in the mutants, our data show
Stevenson et al. Journal of Cell Biology 11 of 18




 http://rupress.org/jcb/article-pdf/220/6/e202005166/1414480/jcb_202005166.pdf by guest on 11 M
ay 2021
that the described differences betweenWT andmutant fractures
largely resolve within 3 wk. This seems insufficient to account
for the number of spontaneous fractures that accumulate, given
that callouses can persist for months overall (Geurtzen et al.,
2014). Combined with the clustered nature of a significant
number of fractures, we believe it likely that the bones are more
brittle. This would be consistent with a defect in type I collagen
deposition, as mutations in the COL1A1 gene are associated with
osteogenesis imperfecta in both humans (Glorieux, 2008) and
zebrafish (Fisher et al., 2003; Gistelinck et al., 2018). Some
N-propeptide processing deficiencies can cause disease with
characteristics of both osteogenesis imperfecta and EDS in hu-
mans (Cabral et al., 2005; Makareeva et al., 2006). Giantin KO
also affects the abundance of other matrix proteins important
for bone quality (Stevenson et al., 2017).
A limitation of our study is that we have been unable to link
the processing defect seen in cell culture with the phenotypes
observed in zebrafish mutants. A simple explanation for this is
that extracellular processing in vivo compensates and precludes
detection of this processing defect. This would be consistent
with the mild impact on matrix organization observed. In cases
of EDS dermatosparaxis type and arthrochalasia type, mutations
in ADAMTS2 or the N-terminus of pro-α1(I)/pro-α2(I), respec-
tively, directly impact N-propeptide cleavage regardless of cel-
lular location or tissue environment. We propose that giantin
acts more indirectly to regulate an intracellular processing
pathway, which works in concert with other complementary
mechanisms, such as extracellular cleavage, for coordinated
and efficient processing under different conditions. This rai-
ses the intriguing possibility of specific pools of collagen that
require intracellular processing for specific functions, such as
fracture repair. It is also possible that the observed pheno-
types have a different underlying mechanism. RNA-seq data
showed that the expression of many matrix components is
altered following loss of giantin (Stevenson et al., 2017), which
must affect matrix quality more globally. Giantin also impacts
ciliary function, which would compound phenotypes (Asante
et al., 2013; Bergen et al., 2017). Further study will be needed
to define which, if any, phenotypes seen in zebrafish are a
direct result of defective N-terminal processing of type I
procollagen.
Materials and methods
Zebrafish husbandry and genetic lines
London AB zebrafish were maintained using standard con-
ditions (Aleström et al., 2020). Ethical approval was obtained
(University of Bristol Ethical Review Committee), and ex-
periments were performed under Home Office Project License
number 30/3804. The golgb1bsl077 (henceforth golgb1X3078) allele
is described in Bergen et al. (2017). The golgb1X3078 allele was
crossed with fish carrying the Tg(col1a1a:EGFP)zf195tg (hence-
forth col1a1a:GFP) transgenic reporter of the 1.4-kb col1a1a
promoter region (Kague et al., 2012). The GFP-positive
golgb1wt/X3078 + col1a1a:GFP individuals were in-crossed to
generate homozygotes. In all experiments, homozygotes were
compared with siblings.
Fin fracture assays
Fin fractures were performed as previously described (Geurtzen
et al., 2014). Briefly, 7-mo-old adult fish were anesthetized with
MS222 (Sigma-Aldrich) and moved into a petri dish with the
head placed on a bed of tissue soaked in anesthetic and the tail
splayed on the dish for imaging. Caudal fins were imaged before
injury, and any pre-existing fractures were counted. Fractures
were induced by pressing on an individual segment of bone in
the tail rays with the end of a semi-flexible plastic pipette tip.
Four fractures per fish were introduced in non-pigmented sec-
tions of fin in the distal third of the tail, avoiding the four most
dorsal and ventral rays. Fish were then reimaged live at various
time points after injury.
Live staining of bone
To visualize bone repair in live zebrafish, ARS and calcein green
stain were used. ARS solution contained 74 µM Alizarin Powder
(Sigma-Aldrich) and 5 mM Hepes dissolved in Danieau’s buffer.
Calcein green staining solution contained 40 µM calcein powder
(Sigma-Aldrich) dissolved in Danieau’s buffer and was pH cali-
brated to pH 7.4. Live fish were immersed in either ARS or
calcein green for 2 h, then immersed in fresh system water for
15 min before imaging to clear excess stain from the fish.
Fluorescence intensity at fracture sites was measured using
ImageJ; lines were drawn along the fracture callous length, and
then the line width was expanded to encompass the whole
fracture. The mean intensity was then measured across this
area, before using the same region of interest to measure the
mean intensity of adjacent, uninjured hemirays. Fracture in-
tensity was then normalized against the healthy bone to account
for differences in baseline expression caused by reporter inte-
gration number.
TEM of zebrafish caudal fin
For caudal fin lysates, two female and two male 8-mo-old
golgb1wt/X3078;col1a1a:GFP+ and golgb1X3078/X3078;col1a1a:GFP+ fish
were anesthetized in MS222 and placed in a petri dish with the
head on a bed of tissue soaked in anesthetic and the tail splayed
on the dish. With a fresh scalpel, the distal third of the caudal fin
was amputated. After recovery in freshwater, the fishwere then
returned to their tanks for 7 d. The regenerated fin tissue was
then amputated as above, cutting as close to the original dis-
section line as possible. The excised tissue was then cut in half to
separate the immature tip of the fin and the more mature tissue.
The tissue was fixed in 2.5% glutaraldehyde, 4% PFA, 0.05 M
cacodylate, 1 mM MgSO4, and 1% sucrose for 4 h at room tem-
perature with gentle agitation. Fins were washed 3× in 0.1 M
cacodylate buffer and incubated in decalcification buffer (0.1 M
EDTA, 0.1 M cacodylate buffer, and 2.5% glutaraldehyde, pH 7.2)
at 4°C for 2 wk, refreshing the buffer after 1 wk. Fins were then
postfixed in a freshly made mixture of 2% osmium tetroxide and
1.5% potassium ferrocyanide in 0.1 M cacodylate buffer for 1 h.
Fix was rinsed off with 3× 5-min washes with water and then
incubated with 1% tannic acid in 0.1 M cacodylate buffer for 2 h.
Tissue was then washed again as before incubating in 2% os-
mium tetroxide in distilled water for 40 min at room tempera-
ture. After a further three washes in distilled water, tissue was
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stained with 1% uranyl acetate overnight before washing again.
The fins were then subjected to a graded dehydration, incubat-
ing them in 50%, 70%, and 90% ethanol, then 100% ethanol four
times for 10 min each. This was followed by a 15-min incubation
in propylene oxide. Samples were gradually infiltrated with
graded TAAB 812 premix kit–Hard-1 (TAAB) in acetone at room
temperature using the following series: 25% TAAB overnight,
50% TAAB through the day, 75% TAAB overnight, and 100%
TAAB for 6 h. Samples were then embedded in fresh 100% TAAB
812 Hard in a labeled mold at 60°C for 48 h. The more mature
pieces of regenerated fins were then sectioned and imaged using
an FEI Tecnai 12 BioTwin transmission electron microscope.
Collecting zebrafish lysates
To collect larval lysates, golgb1X3078/X3078;col1a1a:GFP homozygotes
were out-crossed with EEK strain WT fish to generate hetero-
zygous larvae and also in-crossed for homozygotes. At 5 dpf,
larvae were killed by overdose with MS222, and 20 larvae were
transferred to an Eppendorf for lysis. Larvae were incubated in
Ringers solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2, and
5 mMHepes, pH 7.2) for 30 min and then pipetted up and down
to remove yolk. Tubes were centrifuged at 13,000 ×g for 5 min,
the supernatant was discarded, and 100 µl RIPA buffer + 10%
protease inhibitor cocktail was added per tube. Larvae were
homogenized using a pellet pestle to agitate tissue for 1 min per
sample and then left on ice for 30 min, mixing halfway by
flicking the tube. Lysates were then centrifuged for 30 min at
4°C and 13,000 ×g. The supernatant was analyzed by SDS-PAGE,
and the pellet was discarded.
For caudal fin lysates, 13-mo-old golgbwt//X3078−col1a1a:GFP and
golgb1x3078/X3078;col1a1a:GFP were anesthetized, and the distal
third of the caudal fin was removed as above for TEM and placed
into 200 µl ice-cold PBS. After recovery in fresh water, the fish
were returned to their tanks for 4 d. The fishwere then culled by
overdose in MS222, and the caudal fin was cut again, this time
dissecting ∼2 mm proximal to the original cut site to collect the
regenerated tissue plus a small amount of mature tissue for lysis.
The dissected fins were macerated in the PBS using scissors,
then spun at 13,000 ×g for 4 min at room temperature. Tubes
were put on ice, the PBS was removed, and 100 µl RIPA buffer +
10% protease inhibitor cocktail was added per tube. Tissue was
homogenized for 40 s with a pellet pestle and then incubated for
10 min at 4°C on a shaker. Samples were spun at 13,000 ×g for
10 min at 4°C, and the supernatant was collected for SDS-PAGE
conducted as detailed below.
Cell culture and genome engineering
hTERT-RPE1 cells (American Type Culture Collection) were
grown in DMEM-F12 (Life Technologies) supplemented with
10% decomplemented FCS (Gibco). Cell lines were not authen-
ticated after purchase other than confirming the absence of
mycoplasma contamination. The main GOLGB1 KO hTERT-RPE1
cell line used is described in Stevenson et al. (2017). MC3T3 cells
(MC3T3-E1 ECACC 99072810) were grown in MEMα (nucleo-
sides, no ascorbate; Life Technologies; catalog #A1049001) sup-
plemented with 10% decomplemented FCS (Gibco), 100 U/ml
penicillin, and 100 μg/ml streptomycin.
New hTERT-RPE1 GOLGB1 KO cell lines with mutations in
exon 13 were generated using the lentiCRISPRv2 system (lenti-
CRISPR v2 was a gift from Feng Zhang [Massachusetts Institute
of Technology, Cambridge, MA]; Addgene plasmid #52961;
http://n2t.net/addgene:52961; Research Resource Identifier
[RRID]: Addgene 52961). gRNA sequences were designed using
Benchling (http://benchling.com) and inserted into the lenti-
CRISPRv2 construct as described in Sanjana et al. (2014) and
Shalem et al. (2014) to be coexpressed with Cas9. Target se-
quences used were 59-CCACCGGGAAGCCTTAACCTCCCGCA-39
and 59-AAACTGCGGGAGGTTAAGGCTTCCC-39. The cloned
plasmid was packaged into lentivirus using Lenti X Packaging
Single Shots (Takara; #631275) according to the manufacturer’s
instructions. After harvest, 1 ml virus supernatant was added to
80% confluent RPE1 cells in a 6-cm dish (after removal of growth
media) in the presence of 8 µg/ml polybrene. Virus was incu-
bated for 1 h before adding back fresh growth medium supple-
mented with 8 µg/ml polybrene. Transfection medium was
replaced after 24 h. Cells were passaged 24 h later in 20 µg/ml
puromycin to select transfected cells. After 7 d, individual cells
were FACS sorted into a 96-well plate to grow up clones and
screen for GOLGB1 KO by immunofluorescence and immunoblot.
To identify the mutations, genomic DNA was extracted from
each clone using the Purelink genomic DNA mini kit (In-
vitrogen), and the region targeted by the gRNAs was amplified
by PCR (primers: forward, 59-GCTGGCAGCTGAAGAGCAATT
CCA-39, and reverse, 59-GTTGAGTGTGATGCTGTTCTGTGGCT-
39). PCR products were cloned into the pGEM-T Easy vector
according to the manufacturer’s instructions (Promega) and
sequenced using predesigned primers against the T7 promoter
(MWG Eurofins).
Stable cell lines were made by lentiviral transduction as de-
scribed above using the Lenti X Packaging Single Shots (Takara;
#631275) in combination with the lentiviral vector pLVXpuro-
proSBP–GFP-COL1A1 (Addgene; #110726) described in
McCaughey et al. (2019). To ensure only low levels of over-
expression, all cell lines were FACs sorted. GFP-only stable cells
are described in Asante et al. (2014).
Transient transfections were performed using Lipofectamine
2000 according to the manufacturer’s instructions using 2 µg
DNA for a 35-mm well (Invitrogen; catalog #11668027). Plasmid:
Str-KDEL-IRES-ST-mCherry is described in McCaughey et al.
(2019; Addgene; #110727).
The ALT-R CRISPR-Cas9 system from IDT was used to gen-
erate giantin KO MC3T3 cell lines. Guide RNA1 targeting exon 8
(KO1) was designed using Benchling (59-GGAAAAGGTAGAACT
CGAAG-39), and gRNA2 (KO2) was ordered as a predesigned
guide from IDT targeting exon 2 (59-AATAATGGAATCCACGCA
AG-39 Mm.Cas9.GOLGB1.1.AB). The gRNAs and Cas9 RNPs were
assembled and transfected in a 96-well plate using Cas9 working
buffer (20 mM Hepes and 150 mM KCI, pH 7.5), CRISPRMAX
transfection reagent (Invitrogen; CMAX00008), and 20,000
cells/well according to the IDT published protocols. Cells were
then expanded, and single cells were sorted into a 96-well dish to
generate clones. Again, these were expanded, and giantin KO
clones were identified by immunofluorescence and immuno-
blotting. From 275 cells seeded per gRNA, one KO was obtained
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per target. Genetic mutations were determined as for RPE1 cells
using primers 59-GCCTGCCTTCCTTCCTTTAC-39 and 59-GCG
GAACCAAGCAACAATAC-39 for exon 2 mutations and primers
59-AGTGTTTCAGTGTGCTCCC-39 and 59-GTCTTCTCCATCTCT
GTC-39 for exon 8 mutations.
Antibodies
Rabbit anti-COL1A1 (Novus; catalog #NB600-408; RRID:
AB_10000511), mouse anti-DIC74 (Millipore; catalog #MAB1618;
RRID:AB_2246059), mouse anti-HSP47 (Enzo Life Sciences;
catalog #ADI-SPA-470; RRID:AB_10618557), mouse anti-GM130
(BD Biosciences; catalog #610823; RRID:AB_398142), rabbit anti-
giantin (N-terminus; BioLegend; catalog #924302; RRID:
AB_2565451), rabbit anti-giantin (polyclonal antibodies raised
against full-length giantin originally from Prof. Manfred Renz
[Karlsruhe, Germany], a gift to us fromMartin Lowe, University
of Manchester, Manchester, UK; Lowe et al., 2004), mouse anti-
SBP clone 20 (Millipore; catalog #MAB10764; RRID:
AB_10631872), rabbit polyclonal anti–N- and C-propeptide of
COL1A1 (LF-39 and LF-41, respectively; both gifts from Larry
Fisher, National Institutes of Health, Bethesda, MD; Fisher et al.,
1995), mouse monoclonal anti-GFP (Covance; catalog #MMS-
118P-500; RRID:AB_291290), sheep polyclonal anti-GRASP65
(gift from Jon Lane, University of Bristol, Bristol, UK), tubulin
(Sigma-Aldrich; catalog #T5168; RRID:AB_477579), mouse mon-
oclonal anti-Sec31A (BD Biosciences; catalog #612350; RRID:
AB_399716), and mouse p62 (Novus; catalog #H00008878-D01P;
RRID:AB_1504204). Secondary HRP-conjugated antibodies were
obtained from Jackson ImmunoResearch. Alexa Fluor–
conjugated secondaries were obtained from Invitrogen.
Immunofluorescence
Cells were grown on autoclaved coverslips (0.17-mm thickness;
Thermo Fisher Scientific; #1.5) before fixation with 4% PFA/PBS
for 10 min, permeablization with 1% Triton X-100/PBS for
10 min, and blocking with 3% BSA/PBS for 30 min. Sequential
incubations with primary and secondary antibodies diluted in
blockwere performed for 1 h, washing in PBS in between. Nuclei
were labeled with DAPI (Life Technologies; D1306) for 3 min.
Coverslips were mounted in MOWIOL 4–88 (Merck-Millipore).
All steps were conducted at room temperature and in the dark
after secondary antibody addition. When labeling for ECM, the
Triton permeability step was excluded from the protocol.
For widefield microscopy, an Olympus IX-71 inverted mi-
croscope was used with a 60× 1.42 NA oil-immersion lens, Exfo
Excite xenon lamp illumination, and single-pass excitation,
emission, and multipass dichroic (Semrock) filters. Images were
captured on an Orca-ER charge-coupled device (Hamamatsu).
The systemwas controlled using Volocity (PerkinElmer; v.5.4.1).
Chromatic shifts in images were registration corrected using
TetraSpeck fluorescent beads (Thermo Fisher Scientific). Fixed-
cell imaging by confocal microscopy was performed using a
Leica SP5II system at 1024 × 1024 x-y resolution with a 63× HCX
PL APO CS oil immersion objective, photomultiplier tube de-
tectors, and LAS X software. Tile scans were performed to
capture larger areas of the cell-derived matrix using a
Märzhäuser scanning stage. On both systems, image stacks were
taken with Δz of 0.2 µm, and unless indicated, maximum pro-
jections are shown. Image processing was performed using
ImageJ software (Schindelin et al., 2012).
Preparation of the cell-derived matrix
To prepare the cell-derived matrix, cells were grown for 3 d on
coverslips until they reached confluence, and then 50 µg/ml
L-ascorbic acid-2-phosphate (Sigma-Aldrich) was added to cul-
tures. Cells were left for a further 7 d. To prepare samples, cells
were washed in PBS and extracted using prewarmed extraction
buffer (20 mM NH4OH and 0.5% Triton X-100 in PBS; 3 ml per
6-cm plate for 2 min). After three water washes, residual DNA
was digested with 10 µg/ml DNase I (Roche) for 30 min at 37°C,
and then extracts were washed again. The matrix was fixed in
4% PFA and stained as above.
Live imaging
Procollagen trafficking was analyzed using the RUSH assay
(Boncompain et al., 2012). Cells stably expressing pro-SBP-GFP-
COL1A1 were grown on 35-mm MatTek glass-bottomed dishes
and transfected with Str-KDEL-IRES-ST-mCherry (McCaughey
et al., 2019) 24 h before imaging. Cells were always confluent at
time of imaging.
To image, growth media was replaced with 1 ml prewarmed
Fluorobrite DMEM (Thermo-Fisher Scientific; A1896701), and
the dishes were mounted on a Leica SP8 confocal laser scanning
microscope system with a 63× HC OL APO CS2 1.42 NA glycerol
lens and an environmental chamber at 37°C with CO2 enrich-
ment. Themicroscopewas controlledwith Leica LAS X software.
Once GFP- and mCh-positive cells were identified, 1 ml Fluoro-
brite containing 800 µM biotin and 1 mg/ml L-ascorbic acid-2-
phosphate (Sigma-Aldrich; A92902) was added to the dish (final
concentration 400 µM biotin and 500 µg/ml, respectively) to
induce procollagen folding and synchronous release of the pro-
SBP-GFP-COL1A1 from the ER hook. This is T = 0. Cells were
then imaged live, taking a single confocal plane image every 20
s. Fluorophores were excited using a 65-mW Argon and a 20-
mW solid-state yellow laser and detected using hybrid gallium
arsenide phosphide detectors. Imaging conditions for movies
were 1,024 × 1,024 x-y resolution, scanning speed 600 Hz, 2×
zoom, three-line average, and imaging sequentially between
frames.
To immediately fix during live imaging, 2 ml 8% PFA was
added to the 2 ml Fluorobrite already present at the desired time
point. Cells were fixed for 10 min, and the above immunofluo-
rescence protocol was applied.
Secretion assays, immunoprecipitations (IPs), and cell lysates
To perform secretion assays, medium was aspirated from con-
fluent cells and replaced with a minimal volume of serum-free
DMEM-F12 supplemented with 50 µg/ml L-ascorbic acid-2-
phosphate (Sigma-Aldrich; A92902). Cells were left overnight at
37°C and 5% CO2. Medium was then collected, and the cell layer
was rinsed with PBS, lysed in RIPA buffer (50 mM Tris-HCl, pH
7.5, 300 mM NaCl, 2% Triton X-100, 1% deoxycholate, 0.1% SDS,
and 1 mMEDTA) for 30min rocking on ice and collected without
scraping. Media and lysate fractions were spun at 13,000 ×g at
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4°C for 10 min and the supernatants used for SDS-PAGE. For
collection of lysates in other experiments, cells were scraped in
RIPA buffer, collected in tubes, and incubated on a rotator at 4°C
for 30 min. Bicinchoninic acid assays were performed where
necessary to determine protein concentration according to the
manufacturer’s instructions (Bio-Rad). Samples were boiled in
1× lithium dodecyl sulphate sample buffer (Life Technologies;
NP007) containing sample-reducing agent (Life Technologies;
NP007) for 10 min at 95°C and then analyzed by SDS-PAGE
as below.
For inhibitor experiments, confluent cells were treated with
1 ml serum-free medium containing either DMSO (control),
10 µM MG132, or 200 nM bafilomycin overnight before media
and lysate collection.
For GFP-trap immunoprecipitation, confluent cells were se-
rum starved for 24 h in the presence of 50 µg/µl L-ascorbic acid-
2-phosphate (Sigma-Aldrich; A92902). At the time of assay,
medium was collected and spun at 2,700 ×g for 5 min to remove
dead cells. The cell layer waswashed twice with ice-cold PBS and
lysed in ice-cold buffer (10 mM Tris-HCl, pH 7.4, 50 mM NaCl,
0.5 mM EDTA, 1.0% Igepal CA-630, 1 mM PMSF, and 1× Protease
inhibitor cocktail [Millipore; 539137]) for 30 min with agitation
on a rotator. Lysate supernatant was collected by centrifuging at
20,000 ×g for 10 min, and 66 µl was removed to be used as an
“input” reference sample. Media and lysate supernatants were
then incubated with equilibrated GFP nano-trap beads (Chro-
motek) on a rotator for 2 h. Beads were pelleted by centrifuga-
tion at 2000 ×g for 2 min. The supernatant was removed, but
66 µl was kept as an “unbound” reference sample. The beads
were then washed three times with 500 µl dilution buffer
(10 mM Tris-HCl, pH 7.4, 50 mM NaCl, 0.5 mM EDTA, 1 mM
PMSF, and 1× Protease inhibitor cocktail), pelleting them each
time by centrifugation at 2000 ×g for 2 min. All steps to this
point were performed on ice/at 4°C. Finally, beads were re-
suspended in 88 µl 1× LDS sample buffer (Life Technologies;
NP007) containing sample reducing agent (Life Technologies)
Inbound and unbound samples were mixed with 22 µl 4× LDS
sample buffer + reducing agent (Life Technologies). Samples
were boiled at 95°C for 10 min and analyzed by SDS-PAGE as
outlined below.
Trypsin digest assay
Confluent RPE1 cells were treated with growthmedia + 50 µg/ml
ascorbic acid for 1.5 h at 37°C/5% CO2 to stimulate procollagen
trafficking and then incubated in PBS ± 30 µg/ml digitonin for
2 min at room temperature to permeabilize the cells. Cells were
washed twice in PBS and twice in sucrose buffer (0.3 M sucrose,
0.1 M KCl, 2.5 mMMgCl2, 1 mM sodium-free EDTA, and 10 mM
Pipes, pH 6.8) before incubating with 0.05% trypsin-EDTA for
the indicated time at 37°C/5% CO2. As a control, one well was
incubated with a 1:1 ratio of 0.05% trypsin and 2 mg.ml−1 soy-
bean trypsin inhibitor (Life Technologies; 17075029; dissolved in
PBS). To end the digest, an equal volume of 2 mg/ml soybean
trypsin inhibitor was added to the well and incubated for 10 min
at room temperature. Dishes were scraped, and the cells were
collected and spun at 2,000 ×g for 5 min at 4°C. The supernatant
was removed, and the pellet was washed with 500 µl 2 mg/ml
soybean trypsin inhibitor before repeating the spin and re-
moving the supernatant. The cell pellet was lysed in 85 µl RIPA
buffer containing proteinase inhibitor cocktail (Millipore;
539137) for 30min on rotator at 4°C. Lysates were spun at 13,000
×g/4°C for 10 min, and the supernatant was collected for SDS-
PAGE as below.
Procollagen processing at 20°C
Confluent WT and giantin KO RPE1 cells stably expressing
pro-SBP-GFP-COL1A1 were incubated with 50 µg/ml
L-ascorbic acid-2-phosphate (Sigma-Aldrich; A92902) ±
100 µg/ml cycloheximide for 16 h to promote secretion of
existing procollagen and prevent synthesis of new procolla-
gen, respectively, to remove preexisting protein. As a control
to test the efficiency of the cycloheximide treatment, one
cycloheximide-treated sample was collected after this incu-
bation. Remaining cells were rinsed 3× with PBS and once
with growth media before incubating with CO2 independent
media + 50 µg/ml ascorbic acid overnight at either 20°C or
37°C/5% CO2. Cells were then fixed and stained or used in a
secretion assay as above—including the control that lacked
cycloheximide treatment.
SDS-PAGE
Secretion assays, IP, and lysate samples were separated by SDS-
PAGE on precast 3–8% tris-acetate and 4–12% bis-tris acrylamide
gels (Invitrogen) followed by transfer to 0.2 µm nitrocellulose
membranes (Amersham). Membranes were blocked in 5% milk
0.05% Tween (Sigma-Aldrich) in Tris-buffered saline for at least
1 h. Primary and HRP-conjugated secondary antibodies were
diluted in block and sequentially incubated with the membrane
for 2–16 h each. HRP was detected by enhanced chemilumines-
cence (Promega ECL; GE Healthcare film).
Statistical analyses
Measurements of images and immunoblots were performed
using ImageJ. Statistical analyses were performed using
GraphPad Prism 7.00. The tests used, n numbers, and sample
sizes are indicated in the figure legends; P values where sig-
nificant (P < 0.05) are shown on the figures. All experiments
were analyzed with nonparametric tests as data were assumed
not to be normally distributed. Sample sizes were chosen based
on previous similar experimental outcomes. No samples were
excluded.
Online supplemental material
Fig. S1 shows characterization of fractures, collagen expression,
and collagen fibril morphology in golgb1 HET and HOM zebra-
fish. Fig. S2 contains additional experimental data supporting
the absence of N-terminal procollagen processing in the giantin
KO cells. Fig. S3 details the genetic changes present in the newly
generated giantin KO RPE1 and MC3T3 cells. Fig. S4 shows data
confirming the loss of giantin and absence of procollagen type I
processing in the newly generated giantin KO MC3T3 cells.
Video 1 and Video 2 illustrate synchronized procollagen traf-
ficking inWT (Video 1) and giantin KO (Video 2) RPE1 cells using
the RUSH trafficking system.
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Figure S1. Fracture analysis in WT and mutant zebrafish. (A and B) Quantification of the intensity of ARS (A) and callous width of experimentally induced
fractures (B) normalized to adjacent healthy bone at different time points after injury (D = days after injury) in golgb1wt/X3078 and golgb1X3078/X3078 fish. Dots
represent individual fractures. At time points 4 and 7 dpf, 11 fish per line were quantified. At time points 14 and 21 dpf, n = 6 HETs and n = 4 HOM fish. All from a
single experiment. Horizontal and vertical orange lines depict median and interquartile range, respectively. No significant differences based on P values
calculated with a Mann-Whitney U test comparing the mean value per fish (three fractures per fish). (C) Immunoblots of caudal fin lysates collected from 13-
mo-old golgb1+/−;col1a1a:GFP+ and golgb1−/−;col1a1a:GFP+ fish blotted for pro-α1(I). (D and E) Immunoblots with a pro-α1(I) antibody (D) and a Coomassie-
stained gel of lysates (E) taken from the regenerated fin of the fish 5 d after initial amputation. (D) Each lane shows one representative individual. (E) Each lane
contains sample from a different individual. (F and G) An immunoblot probed with pro-α1(I) (F) and a Coomassie-stained gel of lysates (G) taken from golgb1+/−;
col1a1a:GFP+ and golgb1−/−;col1a1a:GFP+ larvae at 5 dpf. Each sample consists of 20 pooled larvae. (H and I) TEM images of collagen fibrils taken at the outer
edge of the hemiray bone (H) and basement membrane in the skin (I) of regenerated caudal fins fixed 7 dpi. Fish were 8 mo old at the point of assay. Two
females and two males were assayed. All TEM scale bars = 500 nm. A.U, arbitrary units.
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Figure S2. Procollagen processing controls. (A) Immunoblot of a GFP trap of media and lysate fractions of WT and giantin KO RPE1 cell cultures. Cells were
either expressing GFP-COL1A1 or GFP alone as indicated. Blots show the input (I), unbound (U), and bound (B) fractions of the IP immunoblotted for GFP, pro-α1(I)
N-propeptide (LF39 antibody), and tubulin (housekeeping). (B) Immunoblot of HSP47 and DIC74 (housekeeping) in WT and giantin KO RPE1 cell lysates. (C)
Densitometry of the semiquantitative enhanced chemiluminescent immunoblots represented in A. HSP47 levels are normalized to DIC74. Each dot represents an
independent biological replicate, and replicates are color coded between cell lines. Bars show median and interquartile range (n = 5 biological replicates). P value
calculatedwith aMann-Whitney U test. (D) Immunoblots of media (M) and lysate (L) fractions ofWT and giantin KO RPE1 cell cultures stably expressing GFP-COL1A1
following treatment with DMSO (vehicle control), MG132, or bafilomycin (Baf). Blots are probed for GAPDH (housekeeping), GFP (GFP-COL1A1), p62 (positive control
for bafilomycin), and pro-α1(I) (COL1A1) as indicated. A.U, arbitrary units.
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Figure S3. Validating pro-α1(I) processing defect in other giantin KO clones. (A and B) Genomic DNA sequence and amino acid translation at CRISPR/
Cas9 mutation site in three new giantin KO clones targeted at exon 13 (A) and two newMC3T3mutants targeted at exon 8 (B). On theWT sequences, the gRNA
sequence is indicated with a purple line, the cut site is indicated by scissors, and the PAM site is in blue text. In mutant sequences, red text indicates inserted
base pairs in genomic sequence, and green text shows altered amino acids. Asterisks denote premature stop codons.
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Video 1. Representative video of a RUSH assay in a WT RPE1 cell stably expressing GFP-COL1A1 (green) and transiently transfected with mCh-ST
(magenta, Golgi label) and an ER RUSH hook. At time 0, biotin and ascorbic acid were added to the medium to release the collagen from the hook and
promote procollagen folding, respectively, to trigger anterograde trafficking. Video is cropped to the relevant time frame; time is indicated in top left corner as
min:s. Frames were captured as single-frame images every 20 s. Video frame rate: 12 frames/s. Scale bar = 10 µm.
Video 2. Representative video of a RUSH assay in a giantin KO RPE1 cell stably expressing GFP-COL1A1 (green) and transiently transfected with
mCh-ST (magenta, Golgi label) and an ER RUSH hook. At time 0, biotin and ascorbic acid were added to the medium to release the collagen from the hook
and promote procollagen folding, respectively, to trigger anterograde trafficking. Video is cropped to the relevant time frame; time is indicated in top left corner
as min:s. Frames were captured as single-frame images every 20 s. Video frame rate: 12 frames/s. Scale bar = 10 µm.
Figure S4. Procollagen processing in giantin KOMC3T3 cells. (A) Immunoblots of cell lysates taken from WT and giantin KOMC3T3 cells. Antibodies used
are as indicated. (B) Single-plane widefield images of WT and giantin KO MC3T3 cells immunolabeled for giantin (green) and the cis-Golgi marker GM130
(magenta). The nucleus is stained in DAPI. Scale bar = 10 µm. (C) Immunoblots of a GFP trap of WT and giantin KO MC3T3 cell cultures transiently expressing
GFP-COL1A1. Media and lysates were assayed after 24 h of ascorbate treatment, which was conducted 24 h after transfection. The input (I), unbound (U), and
bound (B) fraction of each pull-down is shown probed with either SBP or tubulin antibodies as indicated underneath each blot. Black arrows indicate full-length
procollagen, and red arrows the N-propeptide.
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